Reduced surfactant activity allows surface tension at the alveolar air-liquid interface to rise. During exhalation, that increased tension favors alveolar collapse, so the lungs require greater effort to reopen and inflate. The resulting loss of alveolar stability helps explain reduced lung compliance and the impaired respiratory function associated with surfactant depletion.
Gas exchange depends on maintaining stable, adequately expanded alveoli, not only on keeping the conducting airways open. Surfactant depletion promotes collapse and decreases lung compliance, reducing the effective surface available for oxygen and carbon dioxide exchange. Consequently, ventilation can become less efficient even without an obstruction in the airways themselves.
Surfactant depletion is especially important in respiratory distress syndrome affecting premature infants, where insufficient or impaired surfactant contributes to respiratory difficulty. It can also occur in acute lung injury and other pulmonary disorders. These settings make surfactant status relevant to understanding alveolar instability, impaired gas exchange, and worsening respiratory function.
Identifying surfactant depletion can inform diagnosis and the selection of supportive respiratory strategies. Because the process reduces compliance and promotes alveolar collapse, ventilatory management must be considered in relation to alveolar stability and gas exchange. The same recognition also helps clinicians evaluate whether surfactant replacement strategies may be relevant to the clinical situation.
Surfactant replacement strategies aim to address the consequences of reduced or impaired pulmonary surfactant. By supporting the alveolar surface film, replacement may help preserve alveolar stability, improve the mechanical conditions needed for breathing, and support oxygen and carbon dioxide exchange. This approach is particularly relevant when surfactant depletion contributes to respiratory distress.
Research on surfactant depletion connects molecular changes at the alveolar interface with clinically important outcomes, including reduced compliance, alveolar collapse, and impaired gas exchange. It supports investigation of therapies that preserve surfactant function or stability, while also improving understanding of respiratory distress syndrome, acute lung injury, and related pulmonary disorders.